Status:
WITHDRAWN
Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye Drops
Lead Sponsor:
Sooft Italia
Conditions:
Primary Open Angle Glaucoma
Intraocular Pressure
Eligibility:
All Genders
30-70 years
Brief Summary
Elevated intraocular pressure is still the main risk factor for development and progression of glaucoma. Several drugs exist on the market that may decrease IOP in glaucomatous patients. However, some...
Eligibility Criteria
Inclusion
- Primary Open Angle Glaucoma associated with ocular hypertension
- Target pressure achieved by single-agent therapy (beta-blockers or prostaglandins)
- Visual acuity \> 6/10
Exclusion
- Miopy or Hypermetropy \> 5D
- Concomitant ocular pathologies
- Previous ocular surgery
- Known hypersensitivity to any of the components in the KRONEK tablets
- Concomitant participation in other trials
- Changes of topic glaucoma therapy during the course of the study
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00863811
Start Date
April 1 2009
End Date
July 1 2009
Last Update
June 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology Department of the University
Bari, Italy, I-70124